Title : Pharmacological impact of FLT3 mutations on receptor activity and responsiveness to tyrosine kinase inhibitors.

Pub. Date : 2021 Jan

PMID : 33242449






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Midostaurin and quizartinib are tyrosine kinase inhibitors (TKIs) with inhibitory efficacy against FLT3-ITD, but exhibit limited clinical impact. midostaurin fms related receptor tyrosine kinase 3 Homo sapiens